Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Background Following advances in treatment for hepatitis C (HCV), optimizing linkage to
care and adherence to treatment of people who inject drugs became of pivotal importance …

Importance Extramedical opioid use has escalated in recent years. A better understanding of
cause-specific mortality in this population is needed to inform comprehensive responses …

Background & Aims In 2016, the World Health Assembly passed a resolution to eliminate
viral hepatitis as a public health threat by 2030. We aimed to examine the status of the …

Background & Aims Prisons are key venues for scaling-up hepatitis C virus (HCV) testing
and treatment. Complex clinical pathways and frequent movements of people in prison …

Background Containment policies and other restrictions introduced by the Spanish
government in response to the COVID-19 pandemic present challenges for marginalised …

Background People with HIV have higher risk of hepatocellular carcinoma than the general
population, partly because of higher prevalence of coinfection with hepatitis B virus (HBV) or …

Background People who inject drugs (PWID) represent a population with an increased
prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach …

Abstract Cascade-of-care (CoC) monitoring is an important component of the response to
the global hepatitis C virus (HCV) epidemic. CoC metrics can be used to communicate, in …

Background Direct-acting antiviral (DAA) therapy is highly effective in people who inject
drugs (PWID); however, rates, specific injection behaviors, and social determinants …